Wright Medical Group (NASDAQ: WMGI) announced that its BioMimetic subsidiary has received an approval order from the U.S. Food and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Northland Capital Markets Remains Bullish on Wright Medical Group (WMGI) Following AUGMENT FDA Approval September 2, 2015 9:40 AM Augment Approval Provides Catalyst for Wright Medical (WMGI), Brean Capital SaysSeptember 2, 2015 7:26 AM Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone GraftSeptember 1, 2015 4:00 PM